Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H De Camp

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Chirality|January 1, 1989
The FDA perspective on the development of stereoisomersW H De Camp
Journal of Pharmaceutical and Biomedical Analysis|November 1, 1993
Chiral drugs: the FDA perspective on manufacturing and controlW H De Camp
Chirality|January 1, 1989
Specification of molecular chiralityW H De Camp
Journal - Association of Official Analytical Chemists|September 1, 1984
X-ray powder diffraction data for selected drugs: furosemide, hydrochlorothiazide, naproxen, naproxen sodium, propranolol hydrochloride, and the halopheniramine maleatesW H De Camp
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Chirality|January 1, 1989
The FDA perspective on the development of stereoisomersW H De Camp
Journal of Pharmaceutical and Biomedical Analysis|November 1, 1993
Chiral drugs: the FDA perspective on manufacturing and controlW H De Camp
Chirality|January 1, 1989
Specification of molecular chiralityW H De Camp
Journal - Association of Official Analytical Chemists|September 1, 1984
X-ray powder diffraction data for selected drugs: furosemide, hydrochlorothiazide, naproxen, naproxen sodium, propranolol hydrochloride, and the halopheniramine maleatesW H De Camp
Pageof 1